Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of Combined Immunochemotherapy With Fludarabine, Cyclophosphamide and Rituximab in Patients With B-PLL

NCT00281931 is registered in ClinicalTrials.gov with German CLL Study Group as lead sponsor.

NCT NCT00281931
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00281931 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of Combined Immunochemotherapy With Fludarabine, Cyclophosphamide and Rituximab in Patients With B-PLL
Lead sponsor
German CLL Study Group
Phase
Phase 2
Overall status
Terminated
Start date
September 30, 1999
Completion date
October 31, 2006
Enrollment
21 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prolymphocytic leukemia